69189-0549 : Rifabutin 150 mg Oral Capsule


NDC69189-0549
Labeler: Avera Mckennan Hospital
Product Type: Human Prescription Drug
Drug Name:  Rifabutin
Dosage Form: Oral Capsule
Application #: ANDA090033
Rev. Date: 


Appearance:


Markings: LU;R01
Shapes:  Capsule
Colors:  Brown / Brown
Size (mm): 21
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

LU R01: (60687-198) Rifabutin 150 mg Oral Capsule by Avera Mckennan Hospital
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 69189-0549-1: 1 CAPSULE IN 1 DOSE PACK (69189‑0549‑1)

Active Ingredients:

  • Rifabutin

Dosage Strength:

  • 150 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Crospovidone
  • Ferric Oxide Red
  • Gelatin
  • Magnesium Stearate
  • Potassium Hydroxide
  • Shellac
  • Silicon Dioxide
  • Sodium Lauryl Sulfate
  • Titanium Dioxide

Pharmaceutical Classes:

  • Rifamycin Antimycobacterial [EPC]
  • Rifamycins [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 10135-738 Rifabutin 150 mg Oral Capsule by Marlex Pharmaceuticals, Inc.
  • 59762-1350 Rifabutin 150 mg Oral Capsule by Greenstone LLC
  • 60687-198 Rifabutin 150 mg Oral Capsule by American Health Packaging
  • 68180-285 Rifabutin 150 mg Oral Capsule by Lupin Pharmaceuticals, Inc.
  • 70954-041 Rifabutin 150 mg Oral Capsule by Novitium Pharma LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69189-0549 QR Code

< Prev: 69189-0548Next: 69189-0551 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.